The authors said their findings present a better option for pediatric patients with severe disease.
A recent study showed that children undergoing bilateral lung transplantation for severe pulmonary arterial hypertension (PAH) had a full recovery of their right ventricular (RV) systolic function at the 6-week mark.
Recovery happened within 2 months, wrote the authors, and the results were independent of the patients’ age, weight, and hemodynamic impairment.
The authors used advanced echocardiography and cardiac MRI, followed by conventional and RV strain analysis, pre- and posttransplant, in an effort to clarify some beliefs about this patient population.
The timing of transplants in these children remains challenging, the authors said. Many are referred late or not at all, due to the belief that the transplant operation would not be successful long term in patients with impaired RV function or that their young age and low body weight would prove too challenging to overcome.
This prospective observational study involved 15 patients, aged 1.9 to 17.6 years, undergoing a double lung transplant at Hannover Medical School in Germany between December 2013 and January 2021. Only patients with primary PAH were included, as defined by the World Symposium on Pulmonary Hypertension (PH):
The European Pediatric Pulmonary Vascular Disease Network PH risk score was used to judge the patients’ condition before surgery.
The prospective observational imaging study showed the rapid and full recovery of RV systolic function within 6 weeks, irrespective of the severity of RV dysfunction, age, weight, or need for veno-arterial extracorporeal membrane oxygenation (VA-ECMO) before transplant (the majority of the patients were transplanted while on VA-ECMO).
There was a complete normalization of RV ejection fraction, improving from 30% to 63%, as determined by cardiac MRI. In addition, in contrast to the persistently increased RV mass, RV volumes rapidly normalized.
“Even in end-stage pediatric PAH with poor RV function and low cardiac output, transplant should be preferred over heart-lung transplantation,” wrote the authors.
Reference
Hansmann G, Diekmann F, Chouvarine P, et al. Full recovery of right ventricular systolic function in children undergoing bilateral lung transplantation for severe PAH. J Heart Lung Transplant. 2022;41(2):187-198. doi:10.1016/j.healun.2021.10.014
Why Right Heart Catheterization Confirming PAH Diagnosis May Be Underperformed
November 20th 2024Professional guidelines say that when pulmonary arterial hypertension (PAH) is diagnosed, right heart catheterization should be performed, but a quarter of the time, it isn’t—so investigators set out to discover why.
Read More
Poor Sleep Quality Associated With Pulmonary Arterial Hypertension
November 14th 2024Most patients with pulmonary arterial hypertension (PAH) suffered from poor sleep quality, and dyspnea was a significant predictor of sleep quality, independent of disease severity, according to this study.
Read More
Refinements to European Strategy Can Improve PAH-CHD Stratification
November 6th 2024When patients were re-classified based on the adjusted thresholds of N-terminal pro-brain natriuretic peptide and 6-minute walk distance and the inclusion of TAPSE rather than right atria area, classification of patients improved significantly.
Read More
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More